The difference in CDCA2 mRNA levels between ABC and GCB-DLBCL patients prompted us to examine its expression in refined B-cell subsets including normal B-cell differentiation subsets and B-cell-associated gene signature (BAGS) classification of DLBCL patients. The gene discussed is CDCA2; the disease is diffuse large B-cell lymphoma.